Denise Neves Gameiro, Author at Labiotech.eu

About

Journalist intern. Studied Bioengineering in Porto and was a lab rat in Sweden. Enjoying Berlin and the company of Labiotech’s resident plants.

Articles by Denise Neves Gameiro

biologics 2015 blockbusters best selling drugs

News and Trends 30 Aug 2016

Top 10 Best-selling Biologicals of 2015

Biological drugs have revolutionised disease treatment and their developers have made a killing along the way. We take a look at the top selling biologicals of 2015 – and if they are on their way in or out. Since the beginning of modern biotechnology, with Genentech’s recombinant DNA breakthrough, biologicals have created alternative and more specific treatments for […]

August 30, 2016 - 6 minutesmins - By Denise Neves Gameiro

sanofi novo nordisk diabetes insulin glp 1 agonist combination

News and Trends 22 Aug 2016

Sanofi loses lead on new Diabetes drug, because of… an user-unfriendly Pen

Sanofi and Novo Nordisk have been in a tight race to put their new insulin GLP-1 combination drugs for Type 2 Diabetes on the market. Sanofi now suffers a short (but critical) setback, as the FDA is not impressed with its drug delivery system. Sanofi and Novo Nordisk have both strong positions in the diabetes […]

August 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

sanofi biotech acquisition medivation msd

News and Trends 22 Aug 2016

UPDATE: Sanofi defeated in the Race to acquire Medivation

Even more Big Pharma join the fight to acquire the extremely desirable Medivation, a Biotech developing cancer treatments. Now MSD is joining the bandwagon. Things don’t look so good for Sanofi, which already got rebuffed twice. UPDATE (article originally published on 18/8/2016): Pfizer has struck a deal to acquire Medivation for $14Bn (€12.4Bn), according to the Financial Times. This was […]

August 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

inotrem nancy france inflammation startup

News and Trends 19 Aug 2016

Inotrem on its way to Control Acute Inflammation

We leave the North of Spain, meander through the Pyrenees and prendons un verre du vin français before arriving in Nancy. Here, we can visit the city’s UNESCO World Heritage Site and have a good quiche Lorraine. Then, it’s time to head to Inotrem, our Biotech of the Week. City: Nancy, France Founded: 2013 Employees: 12 Financial Data: €18M […]

August 19, 2016 - 1 minutemin - By Denise Neves Gameiro

News and Trends 18 Aug 2016

This Icelandic Start-Up just raised Money to turn injections into Eye-Drops

Oculis just closed its Series A fundraising with the help of Icelandic investors. The money will help get its first eye-drops in the market, to treat diabetic macular edema (DME) without injections or implants. Based in Reykjavik, Oculis was founded in 2003 to develop a new drug delivery platform. This technology consists of solubilizing nanoparticles (SNP), which […]

August 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

nsclc cancer vaccine immunotherapy opdivo combo

News and Trends 17 Aug 2016

Bavarian Nordic gets hold of Opdivo for new Combination Phase II trial

Just after a major clinical failure, BMS is now shipping Opdivo to Bavarian Nordic for a Phase II trial. Sponsored by Bavarian Nordic, the planned trial will evaluate the combination of a cancer vaccine and the anti-PD-L1 checkpoint inhibitor. Checkpoint blocking has generated a lot of excitement in cancer treatments as part of the immuno-oncology […]

August 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Aug 2016

How did Cancer Cell Therapy become reality?

Using the body’s own tools to eradicate cancers has been a dream of Medicine for quite some time. How did the field of immuno-oncology evolve into today’s Biotech hype? The near-miraculous results of immuno-oncology cell therapies have dominated news about cancer breakthroughs. Indeed, CAR-T is a game-changer and are at the forefront of the ways Biotech […]

August 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

gsk strimvelis gene therapy price commercialization

News and Trends 16 Aug 2016

GSK Pioneers Money Back Guarantee for Biotech Treatments

The second-ever gene therapy to get European approval finally has a price tag. It will be sold at ‘only’ €594k, but with a twist – it has a money-back guarantee. Could this strategy finally get gene therapies some sales action? In May, GSK finally got European approval for a gene therapy, after sparking the resurgence […]

August 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Aug 2016

Gilead licenses Danish Bispecific antibodies for the next HIV Cure

As an add-on to their previously secretive partnership, Genmab is now licensing its bispecific antibodies for Gilead‘s pursuit of an HIV cure for as much as €248M. At the top of the Pyramid of European Biotech value, Genmab is one of the success stories in Copenhagen’s Biotech ecosystem. Its technology for innovative antibodies has allowed it […]

August 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Aug 2016

These 3 Synbio Startups did a ‘perfect pitch’ at IndieBio’s Demo Day

On July 28th 2016, IndieBio EU, the world’s first biotech accelerator, held their demo day in the lovely surroundings of Cork City Gaol. On the night, 13 startups pitched their ideas and products in the hopes of securing investment to take their ideas to the next level. Firebreathers and a live band added the finishing touch to […]

August 15, 2016 - 4 minutesmins - By Denise Neves Gameiro

astrazeneca moderna mrna biotech investing

News and Trends 12 Aug 2016

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

Moderna is taking Biotech investing to new heights, as it has now increased total fundraising&partnership cash to an unbelievable €1.34Bn ($1.5Bn). It can thank AstraZeneca, which is now adding €126M more to its investment. Amid dropping revenues and pipeline cuts, AstraZeneca remains steadily focused on innovation and Biotech. After all, this was the strategy CEO Pascal […]

August 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

hereditary edema KVD818 kalvista protease inhibitor

News and Trends 11 Aug 2016

New First-in-Human trial for rare Hereditary Angioedema begins in the UK

A new drug by KalVista is starting a Phase I trial. The drug could become a preventive treatment for people suffering for hereditary angioedema, a rare genetic condition that can be life-threatening. Based in the Tetricus Science Park (UK), KalVista targets proteases that are involved in diseases. It develops small molecule inhibitors for plasma kallikrein, an enzyme involved […]

August 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Denise Neves Gameiro

About

Articles by Denise Neves Gameiro

Top 10 Best-selling Biologicals of 2015

Sanofi loses lead on new Diabetes drug, because of… an user-unfriendly Pen

UPDATE: Sanofi defeated in the Race to acquire Medivation

Inotrem on its way to Control Acute Inflammation

This Icelandic Start-Up just raised Money to turn injections into Eye-Drops

Bavarian Nordic gets hold of Opdivo for new Combination Phase II trial

How did Cancer Cell Therapy become reality?

GSK Pioneers Money Back Guarantee for Biotech Treatments

Gilead licenses Danish Bispecific antibodies for the next HIV Cure

These 3 Synbio Startups did a ‘perfect pitch’ at IndieBio’s Demo Day

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

New First-in-Human trial for rare Hereditary Angioedema begins in the UK

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Denise Neves Gameiro

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!